AstraZeneca PLC Ordinary Shares (AZN)
EBITDA Margin
33.56%
Quarterly · Period ending:
AZN EBITDA Margin
Latest reported33.56%period ending
Latest reported33.56%period ending
AZN Quarterly EBITDA Margin (100.00% → 33.56%)
Quarterly ebitda margin
High-resolution chart · PNG
AZN ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 33.5608% | |
| 37.1075% | |
| 29.8759% | |
| 34.4085% | |
| 34.2741% | |
| 37.0548% | |
| 18.8637% | |
| 30.2396% | |
| 31.8365% | |
| 35.2394% | |
| 22.4883% | |
| 28.9419% | |
| 33.2428% | |
| 37.9539% | |
| 23.6389% | |
| 23.6296% | |
| 17.7792% | |
| 19.2976% | |
| 15.5524% | |
| 11.3724% | |
| 22.4209% | |
| 36.9945% | |
| 30.3779% | |
| 30.0699% | |
| 31.8725% | |
| 33.176% | |
| 33.0732% | |
| 23.0721% | |
| 21.106% | |
| 32.7991% | |
| 41.7017% | |
| 28.8202% | |
| 28.5354% | |
| 27.5396% | |
| 28.9943% | |
| 29.1881% | |
| 30.8058% | |
| 29.2322% | |
| 55.8281% | |
| 28.8121% | |
| 16.045% | |
| 26.4432% | |
| 27.7231% | |
| 29.4029% | |
| 26.1614% | |
| 29.5196% | |
| 10.4893% | |
| 21.3194% | |
| 26.8707% | |
| 24.195% | |
| 29.5733% | |
| 33.728% | |
| 34.4352% | |
| 32.4197% | |
| 39.014% | |
| 43.5498% | |
| 35.8709% | |
| 36.277% | |
| 37.6964% | |
| 60.3677% | |
| 42.847% | |
| 49.0111% | |
| 44.6443% | |
| 39.6429% | |
| 43.9105% | |
| 48.7057% | |
| 36.1096% | |
| 46.2439% | |
| 42.8374% | |
| 47.5393% | |
| 26.6325% | |
| 42.2765% | |
| 38.6878% | |
| 41.9044% | |
| 21.7625% | |
| 39.2168% | |
| 35.4874% | |
| 40.0086% | |
| 25.3005% | |
| 40.7612% | |
| 39.8038% | |
| 36.5372% | |
| 24.5943% | |
| 41.7689% | |
| 32.3549% | |
| 32.7529% | |
| -55.2509% | |
| 27.7873% | |
| 25.6241% | |
| 27.3157% | |
| 23.959% | |
| 33.3791% | |
| 24.0416% | |
| 33.0518% | |
| 20.539% | |
| 26.6687% | |
| 30.0557% | |
| 35.0667% | |
| 29.9047% | |
| 30.9873% |